QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
one-third of one redeemable warrant |
The | |||
The | ||||
The |
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
| Emerging growth company | ||||||
Page |
||||
1 |
||||
1 |
||||
2 |
||||
3 |
||||
4 |
||||
5 |
||||
16 |
||||
18 |
||||
18 |
||||
19 |
||||
19 |
||||
20 |
||||
20 |
||||
20 |
||||
20 |
||||
21 |
||||
22 |
||||
Item 1. |
Condensed Financial Statements. |
March 31, 2022 |
December 31, 2021 |
|||||||
(unaudited) |
||||||||
| ASSETS |
||||||||
| Current assets |
||||||||
| Cash |
$ | $ | ||||||
| Prepaid expenses and other current assets |
||||||||
| |
|
|
|
|||||
| Total Current Assets |
||||||||
| Deferred offering costs |
||||||||
| Investments held in Trust Account |
||||||||
| |
|
|
|
|||||
| TOTAL ASSETS |
$ |
$ |
||||||
| |
|
|
|
|||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
||||||||
| Current liabilities |
||||||||
| Accrued expenses |
$ | $ | ||||||
| Advance from related parties |
||||||||
| Promissory note – related party |
||||||||
| |
|
|
|
|||||
| Total Current Liabilities |
||||||||
| Deferred underwriting fee payable |
||||||||
| Warrant liabilities |
||||||||
| |
|
|
|
|||||
| Total Liabilities |
||||||||
| |
|
|
|
|||||
| Commitments and Contingencies |
||||||||
| Class A ordinary shares subject to possible redemption and |
||||||||
| Shareholders’ Deficit |
||||||||
| Preference shares, $ or outstanding |
||||||||
| Class A ordinary shares, $ or outstanding (excluding |
||||||||
| Class B ordinary shares, $ |
||||||||
| Additional paid-in capital |
— | |||||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total Shareholders’ Deficit |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
$ |
$ |
||||||
| |
|
|
|
|||||
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
| General and administrative expenses |
$ | $ | ||||||
| |
|
|
|
|||||
| Loss from operations |
( |
) |
( |
) | ||||
| Other income: |
||||||||
| Income earned on investments held in Trust Account |
||||||||
| Interest expense |
— | ( |
) | |||||
| Transaction costs allocated to warrant liabilities |
— | ( |
) | |||||
| Change in fair value of warrant liabilities |
||||||||
| |
|
|
|
|||||
| Total other income, net |
||||||||
| |
|
|
|
|||||
| Net income |
$ |
$ |
||||||
| |
|
|
|
|||||
| Weighted average shares outstanding, Class A ordinary shares |
||||||||
| |
|
|
|
|||||
| Basic net income per share, Class A ordinary shares |
$ |
$ |
||||||
| |
|
|
|
|||||
| Basic weighted average shares outstanding, Class B ordinary shares |
||||||||
| |
|
|
|
|||||
| Basic net income per share, Class B ordinary shares |
$ |
$ |
||||||
| |
|
|
|
|||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
||||||||||||||||||||||
| Balance — January 1, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2022 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
| Balance — January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
| Cash paid in excess of fair value of Private Placement warrants |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
| Accretion for Class A ordinary shares to redemption amount |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
For the Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
| Cash Flows from Operating Activities: |
||||||||
| Net income |
$ | $ | ||||||
| Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
| Income earned on investments held in Trust Account |
( |
) | ( |
) | ||||
| Change in fair value of warrant liabilities |
( |
) | ( |
) | ||||
| Transaction costs allocated to warrant liabilities |
— | |||||||
| Changes in operating assets and liabilities: |
||||||||
| Prepaid expenses and other current assets |
( |
) | ||||||
| Accrued expenses |
||||||||
| |
|
|
|
|||||
| Net cash used in operating activities |
( |
) |
( |
) | ||||
| |
|
|
|
|||||
| Cash Flows from Investing Activities: |
||||||||
| Investment of cash into Trust Account |
— | ( |
) | |||||
| |
|
|
|
|||||
| Net cash used in investing activities |
— |
( |
) | |||||
| |
|
|
|
|||||
| Cash Flows from Financing Activities: |
||||||||
| Proceeds from sale of Units, net of underwriting discounts paid |
— | |||||||
| Proceeds from sale of Private Placement Warrants |
— | |||||||
| Proceeds from advances from related party |
— | — | ||||||
| Proceeds from promissory note – related party |
— | |||||||
| Repayment of promissory note – related party |
— | ( |
) | |||||
| Payment of offering costs |
— | ( |
) | |||||
| |
|
|
|
|||||
| Net cash provided by financing activities |
||||||||
| |
|
|
|
|||||
| Net Change in Cash |
( |
) |
||||||
| Cash – Beginning |
— | |||||||
| |
|
|
|
|||||
| Cash – Ending |
$ |
$ |
||||||
| |
|
|
|
|||||
| Non-cash investing and financing activities: |
||||||||
| Deferred underwriting fee payable |
$ | — | $ | |||||
| |
|
|
|
|||||
| Gross proceeds |
$ | |||
| Less: |
||||
| Proceeds allocated to Public Warrants |
( |
) | ||
| Class A ordinary shares issuance costs |
( |
) | ||
| Plus: |
||||
| Accretion of carrying value to redemption value |
||||
| |
|
|||
| Class A ordinary shares subject to possible redemption |
$ |
For the Three Months Ended March 31, |
||||||||||||||||
2022 |
2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
| Basic and diluted net income per ordinary share |
||||||||||||||||
| Numerator: |
||||||||||||||||
| Allocation of net income, adjusted for |
$ | $ | $ | $ | ||||||||||||
| Denominator: |
||||||||||||||||
| Basic and diluted weighted average shares outstanding |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Basic and diluted net income per ordinary share |
$ | $ | $ | $ | ||||||||||||
| • | in whole and not in part; |
| • | at a price of $0.01 per warrant; |
| • | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
| • | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
• |
in whole and not in part; |
| • | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; |
| • | if, and only if, the closing price of the Class A ordinary shares equal or exceeds $10.00 per public share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption of the warrant holders; and |
| • | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
| Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
| Level 3: | Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. | |
March 31, 2022 |
Level |
Fair Value |
||||||
| Assets: |
||||||||
| Investment held in Trust Account –Money Market Fund |
1 |
$ |
||||||
| Liabilities: |
||||||||
| Warrant Liability – Public Warrants |
1 |
|||||||
| Warrant Liability – Private Placement Warrants |
2 |
|||||||
| |
|
|
|
|
|
| ||
December 31, 2021 |
||||||||
| Assets: |
||||||||
| Investment held in Trust Account –Money Market Fund |
1 | $ | ||||||
| Liabilities: |
||||||||
| Warrant Liability – Public Warrants |
1 | |||||||
| Warrant Liability – Private Placement Warrants |
2 | |||||||
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds. |
Item 3. |
Defaults Upon Senior Securities |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Other Information |
Item 6. |
Exhibits |
No. |
Description of Exhibit | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101 | |
| * | Filed herewith. |
| TZP STRATEGIES ACQUISITION CORP. | ||||
| Date: May 16, 2022 | By: | /s/ Samuel Katz | ||
| Name: | Samuel Katz | |||
| Title: | Chief Executive Officer and Director (Principal Executive Officer) | |||
| Date: May 16, 2022 | By: | /s/ Sheera Michael | ||
| Name: | Sheera Michael | |||
| Title: | (Principal Financial Officer and Principal Accounting Officer) | |||